Theralase Technologies Inc.
TLT.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.10M | -3.06M | -3.20M | -3.11M | -3.18M |
| Total Depreciation and Amortization | 187.00K | 189.00K | 193.60K | 198.70K | 202.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 508.60K | 472.20K | 424.20K | 404.50K | 373.00K |
| Change in Net Operating Assets | 601.00K | 81.50K | 708.30K | 69.80K | -419.60K |
| Cash from Operations | -1.81M | -2.31M | -1.87M | -2.44M | -3.03M |
| Capital Expenditure | -69.00K | -64.30K | -56.80K | -14.50K | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -69.00K | -64.30K | -56.80K | -14.50K | -18.00K |
| Total Debt Issued | 100.00K | -- | -- | -- | -- |
| Total Debt Repaid | -135.90K | -130.10K | -123.80K | -117.10K | -121.80K |
| Issuance of Common Stock | 2.40M | 3.04M | 2.81M | 3.69M | 4.36M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.00K | -2.00K | -2.00K | -2.00K | 0.00 |
| Cash from Financing | 1.70M | 2.11M | 1.95M | 2.62M | 3.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | -175.50K | -273.20K | 18.00K | 165.80K | 68.70K |